Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

Cost-Effectiveness of Fecal Immunochemical Testing Alone vs Co-Testing With Helicobacter pylori Stool Antigen

Дата публикации: 07-07-2026 00:00:00

This cost-effectiveness analysis assesses the lifetime health benefits and costs of invitation to 1-time Helicobacter pylori stool antigen testing added to biennial fecal immunochemical test (FIT) screening compared with FIT alone.

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1E coli-produced HPV vaccine effective against cancer-causing strains of HPV014.2208-07-2026
2Cost-Effectiveness of Perioperative Pembrolizumab in Locally Advanced Head and Neck Cancer0702-07-2026
3Comparison of Diet and Lifestyle Program With 3 Medication Approaches for Laryngopharyngeal Reflux Disease0702-07-2026
4When alleging cause for dismissal becomes an employer's costliest mistake08.2121-07-2026
5Women often opt for self-collection HPV screening, new studies show015.5429-07-2026
6Neoadjuvant Immune Checkpoint Inhibitors in Early Breast Cancer07.6401-10-2024
7Statistical test helps judge the value of personalization09.9114-07-2026
8Recoverability of costs01003-08-2026
9Healthcare affordability07.5913-07-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 9.77. Источник: jamanetwork.com.